Novilla is building a new class of localized medicines, designed by AI to work only where they’re needed.
By bypassing the bloodstream, we dramatically reduce systemic side effects while increasing effectiveness at the site of disease. Our mission is to transform pain care and help end the opioid epidemic by enabling powerful treatments without the addiction risks created by whole-body exposure.
Precision Therapy for Safer Healing
Clinical Breakthrough
Novilla’s first drug candidate designed by our proprietary AI Algorithim, NOV-1776, recently finished human clinical trials showing a 212% increase in efficacy over the standard of care with <1% systemic exposure and 0% GI AEs
Our Company
Harnessing chemical thermodynamic machine learning algorithms to design therapeutics that administer efficacious drugs using a unique delivery mechanism.
Our team of pioneers in pain therapeutics, innovators in chemical thermodynamics and experts in rational formulation design unite decades of innovation across pain medicine, chemistry, and AI drug development. Together with specialists in regulatory strategy and translational research, we're creating a new class of targeted therapies—designed to act precisely where needed, without exposing the rest of the body.
Leadership Team
Dr. Shashi Kori
Dr. Shashi Kori is a Neurologist and Neuro-Oncologist with 22 years of research and teaching experience . He served as a founder and director at major universities such as USF and Duke University. With over 2 decades of experience in the drug development industry including GSK, Allergan, and MAP Pharmaceuticals, Dr. Kori brings a wealth of knowledge for medicine and the pharmaceutical industry.
Dr. Tracey Rapp
Dr. Rapp received her B.S in Chemistry from Purdue, M.S. in Analytical Chemistry from the University of Michigan, Ph.D. in Analytical Chemistry from the University of Michigan, and her M.S. in Quality Assurance and Regulatory Affairs from Temple University. With over 20 years of experience including 18 years at Pfizer and various small biotechs, Dr. Rapp brings an impressive knowledge of the pharmaceutical industry- from GxP work to in vivo, in vitro and clinicals.
Ajay Kori
Ajay is an entrepreneur with a history of solving big problems with novel solutions. Prior to founding Novilla, Ajay founded UrbanStems, Allay Lamp, Autodream and served as an Associate Director of Pet Meds heading the team launching Amazon’s first ever online pet pharmacy. Ajay obtained his BS in Chemistry from Duke University before attending Harvard Business School for his MBA.